Trial intelligence / Profile preview

Efficacy and Safety of Atozet in Japanese Patients With Hypercholesterolemia

NCT02550288Phase 3Completed

Sponsor
Organon & Co.
Start
Sep 2015
Primary completion
May 2016
Modality
Small Molecules
01

Overview

A Phase 3 trial of atorvastatin + ezetimibe in hypercholesterolemia, sponsored by Organon & Co.. Started Sep 2015; status: completed.

02

Drugs

atorvastatin + ezetimibe
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT02550288.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02550288.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call